Lamkin EN, Shimony S, Mehra S, Lane A, Taylor J. Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines. Haematologica; https://doi.org/10.3324/haematol.2026.301363 [Early view].